Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy

Muscle and Nerve

Volumn 42, Issue 6, 2010, Pages 864-870

  Gironi, Maira ^a,d   Saresella, Marina ^a   Marventano, Ivana ^a   Guerini, Franca Rosa ^a   Gatti, Andrea ^a   Antonini, Giovanni ^b   Ceresa, Lara ^a   Morino, Stefania ^b   Beghi, Ettore ^c   Angelici, Alberto ^d   Mariani, Enrica ^d   Nemni, Raffaello ^a,e   Clerici, Mario ^a,e  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d Centro Analisi Mediche   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic dysimmune neuropathies; Cytokines; Immunology; Inflammation; Neuroscience

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MYELIN ASSOCIATED GLYCOPROTEIN;

AGED; ARTICLE; CHRONIC DYSIMMUNE NEUROPATHY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE DYSREGULATION; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYNEUROPATHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; POLYNEUROPATHIES; T-LYMPHOCYTES;

EID: 78649676937     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21786     Document Type: Article

References (28)

1. Busby M, Donaghy M. Chronic dysimmune neuropathy. J Neuroimmunol 2003;250:714-724.
2. Isoardo G, Migliaretti G, Ciaramitaro P, Rota E, Poglio F, Tavella A, et al. Differential diagnosis of chronic dysimmune demyelinating polyneuropathies with and without anti-MAG antibodies. Muscle Nerve 2005;31:52-58.
3. Horiuchi I, Ochi H, Murai H, Osoegawa M, Minohara M, Furuya H, et al. Th2 shift in mononeuritis multiplex and increase of Th2 cells in chronic inflammatory demyelinating polyneuropathy: an intracellular cytokine analysis. J Neurol Sci 2001;193:49-52. (Pubitemid 33062395)
4. Mei FJ, Ishizu T, Murai H, Osoegawa M, Minohara M, Zhang KN, et al. Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF. J Neurol Sci 2004;228:75-85.
5. Lindenlaub T, Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 2003;105:593-602. (Pubitemid 36798860)
6. Decaux O, Laurat E, Perlat A, Cazalets C, Jego P, Grosbois B. Systemic manifestations of monoclonal gammopathy. Eur J Intern Med 2009;20:457-461.
7. Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-332.
8. Hadden RD, Nobile-Orazio E, Sommer C, Hahn A, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:809-818. (Pubitemid 44124676)
9. Renaud S, Hays AP, Brannagan TH III, Sander HW, Edgar M, Weimer LH, et al. Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2005;159:203-214. (Pubitemid 40126194)
10. Dalakas MC, Engel WK. Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch Neurol 1980;37:637-640.
11. Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1993;47:55-61.
12. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996;19:474-487. (Pubitemid 26104298)
13. Créange A, Barlovatz-Meimon G, Gherardi RK. Cytokines and peripheral nerve disorders. Eur Cytokine Networks 1997;8:145-151.
14. Latov N, Renaud S. Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies. J Neurol Sci 2004;220:127-129.
15. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009;361:888-898.
16. Gorson KC. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS). J Clin Apher 1999;14:149-153.
17. Steck AJ, Stalder AK, Renaud S. Anti-myelin-associated glycoprotein neuropathy. Curr Opin Neurol 2006;19:458-463.
18. Nobile-Orazio E, Francomano E, Daverio R, Barbieri S, Marmiroli P, Manfredini E, et al. Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. Ann Neurol 1989;26:543-550. (Pubitemid 19247231)
19. Vrethem M, Skogh T, Berlin G, Holmgren H, Ernerudh J. Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons. J Neuroimmunol 1991;32:219-222.
20. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991;30:54-61.
21. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
22. Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA. Interleukin-10 promoter polymorphisms in patients with Guillain- Barré syndrome. J Neuroimmunol 2003;139:81-83. (Pubitemid 36694393)
23. González García ME, Fernández Alvarez C, Robles Marinas V, González Huerta AJ, Arias Miranda MI, González Rodríguez AP, et al. A series of 618 cases of monoclonal gammopathies of undetermined significance: predictive factors of disappearance of monoclonal component or evolution to malignant gammopathies. Rev Clin Esp 2008;208:288-294.
24. Peters M, Jacobs S, Ehlers M, Vollmer P, Müllberg J, Wolf E, et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 1996;183:1399-1406.
25. Kishimoto T. Interleukin-6: from basic science to medicine - 40 years in immunology. Annu Rev Immunol 2005;23:1-21. (Pubitemid 40563163)
26. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994;83:113-118.
27. Leemans JC, Vervoordeldonk MJ, Florquin S, van Kessel KP, van der Poll T. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am J Respir Crit Care Med 2002;165:1445-1450.
28. Van den Bergh PY, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004;29:565-574. (Pubitemid 38451348)